Preclinical evaluation of the efficacy of a novel 5-HT2CR agonist to reduce binge-eating behavior

Project: Other project

Project Details

StatusFinished
Effective start/end date10/15/203/31/22

Funding

  • Bright Minds Biosciences: $8,709.00